Logo-bi
Editorial
Ghaith Aljayyoussi, Muthanna Abdulkarim, Peter Griffiths, Mark Gumbleton*
Bioimpacts. 2012;2(4): 173-174. doi: 10.5681/bi.2012.029
PMCID: PMC3648940     PMID: 23678457     Scopus ID: 84876813203    
PDF
XML
Cited By:
Review
Syed Baker, Devaraju Rakshith, Kumara Shanthamma Kavitha, Parthasarathy Santosh, Holalu Umapathy Kavitha, Yashavantha Rao, Sreedharamurthy Satish*
Bioimpacts. 2013;3(3): 111-117. doi: 10.5681/bi.2013.012
PMCID: PMC3786792     PMID: 24163802     Scopus ID: 84887362816    
Review
Mohammad Babaei, Maryam Ganjalikhani*
Bioimpacts. 2014;4(1): 15-20. doi: 10.5681/bi.2014.003
PMCID: PMC4005278     PMID: 24790894     Scopus ID: 84900495085    
PDF
XML
Cited By:
Review
Samira Jafari, Solmaz Maleki Dizaj, Khosro Adibkia*
Bioimpacts. 2015;5(2): 103-111. doi: 10.15171/bi.2015.10
PMCID: PMC4492185     PMID: 26191505     Scopus ID: 84930392449    
Original Research
Maryam Khalkhali, Somayeh Sadighian, Kobra Rostamizadeh*, Farhad Khoeini, Mehran Naghibi, Nahid Bayat, Mina Habibizadeh, Mehrdad Hamidi
Bioimpacts. 2015;5(3): 141-150. doi: 10.15171/bi.2015.19
PMCID: PMC4597162     PMID: 26457252     Scopus ID: 84941794675    
Short Communication
Morteza Mahmoudi, Mingming Zhao, Yuka Matsuura, Sophie Laurent, Phillip C. Yang, Daniel Bernstein, Pilar Ruiz-Lozano*, Vahid Serpooshan*
Bioimpacts. 2016;6(2): 111-115. doi: 10.15171/bi.2016.16
PMCID: PMC4981249     PMID: 27525229     Scopus ID: 84983548259    
Short Communication
Inna Garmasheva*, Nadezhda Kovalenko, Sergey Voychuk, Andriy Ostapchuk, Olena Livins’ka, Ljubov Oleschenko
Bioimpacts. 2016;6(4): 219-223. doi: 10.15171/bi.2016.29
PMCID: PMC5326670     PMID: 28265538     Scopus ID: 85013031052    
Review
Saeideh Same, Ayuob Aghanejad, Sattar Akbari Nakhjavani, Jaleh Barar ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2016;6(3): 169-181. doi: 10.15171/bi.2016.23
PMCID: PMC5108989     PMID: 27853680     Scopus ID: 85004064338    
Original Research
Mahdi Mohseniazar, Mohsen Barin, Habib Zarredar, Siamak Alizadeh, Dariush Shanehbandi*
Bioimpacts. 2011;1(3): 149-152. doi: 10.5681/bi.2011.020
PMCID: PMC3648959     PMID: 23678420    
PDF
XML
Cited By:
Original Research
Mohsen Ebrahimi, Mohammad Johari-Ahar, Hossein Hamzeiy*, Jaleh Barar ORCID, Omid Mashinchian, Yadollah Omidi* ORCID
Bioimpacts. 2012;2(2): 91-95. doi: 10.5681/bi.2012.013
PMCID: PMC3648926     PMID: 23678446     Scopus ID: 84865375417    
PDF
XML
Cited By:
Original Research
Mojtaba Taran, Maryam Rad, Mehran Alavi*
Bioimpacts. 2018;8(2): 81-89. doi: 10.15171/bi.2018.10
PMCID: PMC6026522     PMID: 29977829     Scopus ID: 85045120368    
Original Research
Mostafa Akbarzadeh Khiavi ORCID, Azam Safary ORCID, Jaleh Barar ORCID, Hamed Farzi-Khajeh, Abolfazl Barzegari, Rahimeh Mousavi, Mohammad Hossein Somi* ORCID, Yadollah Omidi* ORCID
Bioimpacts. 2020;10(1): 27-36. doi: 10.15171/bi.2020.04
PMCID: PMC6977588     PMID: 31988854     Scopus ID: 85078959970    
The current study introduces an efficient ROS-responsive enzyme-based nanobiosystem and its biological impact in colon cancer therapy. Based on physicochemical properties, AuNPs-PEG-RNase A effectively induced apoptosis in SW-480 colon cancer cells and resulted in a significant reduction in cancer cell viability.
Original Research
Maryam Asariha ORCID, Azam Chahrdoli, Farshad Qalekhani, Mahnaz Ghowsi, Mehdi Fouladi, Maryam Gholamhosseinpour, Ali Fattahi* ORCID
Bioimpacts. 2020;10(4): 217-226. doi: 10.34172/bi.2020.28
PMCID: PMC7502908     PMID: 32983937     Scopus ID: 85092035841    
In this study biocompatible gold nanoparticles (GNPs) were synthesized using chondroitin sulfate (CHS) as reducing and capping materials. CHS-GNPs were characterized (UV, XRD-FTIR and TEM) and their biological (antibacterial, antioxidant and cytotoxicity effects and blood compatibility) and electrochemical properties were evaluated.
Original Research
Shahram Parvaneh ORCID, Fatemeh Khademi, Gisya Abdi, Abdolhamid Alizadeh, Ali Mostafaie* ORCID
BioImpacts. 2021;11(4): 237-244. doi: 10.34172/bi.2021.34
PMCID: PMC8494260     PMID: 34631485     Scopus ID: 85113738808    
We could fabricate stable and high active Fe3O4@SiO2/NH2, and antibodies were conjugated to the surface of them from the Fc region, causing a higher binding capacity with no alteration or inhibition in the paratope area of the antibody molecule.
Original Research
Ranjita Misra* ORCID, Bamadeb Patra, Sudha Varadharaj, Rama Shanker Verma* ORCID
BioImpacts. 2021;11(3): 199-207. doi: 10.34172/bi.2021.27
PMCID: PMC8314031     PMID: 34336608     Scopus ID: 85109081197    
Formulation of siRNA adsorbed drug loaded cationic PLGA NPs. Treatment of cells with siRNA adsorbed drug loaded cationic NPs leads to endosomal escape of drugs and siRNA, thereby increasing the efficiency of the therapeutic components inducing more cytotoxicity.
Original Research
Soheila Rostami ORCID, Farzaneh Tafvizi* ORCID, Hamid Reza Kheiri Manjili
BioImpacts. 2022;12(4): 301-313. doi: 10.34172/bi.2021.23337
PMCID: PMC9376161     PMID: 35975200     Scopus ID: 85138644192    
The findings suggest that F-Lys-TMX NPs are more effective and have the potential for cell proliferation inhibition and apoptosis induction compared to the TMX. Hence, F-Lys-TMX NPs can be considered as an anti-cancer agent against MCF-7 breast cancer cells.
Schematic of the microfluidic device, top view and cross section of the middle part of the microfluidic device, tumor cell labeled with the functionalized antibodies with the Fe3O4 PMNPs, surface functionalization of the Si nanowires, SEM images of the middle part of the Si substrate with well-aligned SiNWs, SEM images of the tilted view of cancer cells trapped on the nanowires substrate microfluidic channel.
Original Research
Zhengmin Liang ORCID, Miaoxuan Li, Jiamin Ni, Tariq Hussain, Jiao Yao, Yinjuan Song, Yiduo Liu, Haoran Wang, Xiangmei Zhou* ORCID
BioImpacts. 2022;12(5): 395-404. doi: 10.34172/bi.2022.23645
PMCID: PMC9596879     PMID: 36381632     Scopus ID: 85140257880    
CFP10-NPs significantly enhanced the secretion of TNF-α and IL-1β in J774A.1 macrophages. Mucosal immunization with CFP10-NPs significantly increased the levels of TNF-α, IL-1β, IgA and CFP10-specific IFN-γ, and decreased bacterial load in lungs and spleen of M. bovis-infected mice.
Original Research
Behnaz Babaye Abdollahi ORCID, Marjan Ghorbani, Hamed Hamishehkar, Reza Malekzadeh, Alireza Farajollahi* ORCID
Bioimpacts. 2023;13(1): 17-29. doi: 10.34172/bi.2022.23682
PMCID: PMC9923814     PMID: 36816996     Scopus ID: 85152117585    
This study shows the positive effect of synthesized Trastuzumab loaded PEG-Fe3O4@Au nanoparticleson increasing the death rate of Breast cancer cells during megavoltage radiation therapy.
Original Article
Tina Sepasi ORCID, Farhad Bani, Reza Rahbarghazi, Abbas Ebrahimi-Kalan, Mohammad-Reza Sadeghi, Seyedeh Zahra Alamolhoda, Amir Zarebkohan* ORCID, Tahereh Ghadiri, Huile Gao
Bioimpacts. 2023;13(2): 133-144. doi: 10.34172/bi.2022.23876
PMCID: PMC10182443     PMID: 37193076     Scopus ID: 85152096867    
Efficient gene delivery to the brain using CDX-modified chitosan nanoparticles. Given the vital effects ofcargo's physicochemical features on the targeting ability of functionalized nanoparticles, we successfullyevaluated the brain accumulation of the mentioned nanocomplexes and their distribution in the brain ofmice
Original Article
Arezoo Gohari Mahmoudabad ORCID, Fatemeh Gheybi, Mohsen Mehrabi* ORCID, Alireza Masoudi, Zeinab Mobasher, Hamid Vahedi, Anneh Mohammad Gharravi, Fatemeh Sadat Bitaraf, Seyed Mahdi Rezayat Sorkhabadi
Bioimpacts. 2023;13(4): 301-311. doi: 10.34172/bi.2023.24128
PMCID: PMC10460772     PMID: 37645028     Scopus ID: 85168161377    
Phytosome silymarin nanoparticles effectively improved ethanol-induced liver damage in models of rats with alcoholic liver disease (ALD) and showed higher beneficial effects and less toxicity compared to the bulky form of phytosome silymarin nanoparticles.
Original Article
Nahid Moradi ORCID, Saeid Kaviani* ORCID, Mina Soufizomorrod* ORCID, Simzar Hosseinzadeh* ORCID, Masoud Soleimani ORCID
Bioimpacts. 2023;13(5): 425-438. doi: 10.34172/bi.2022.24142
PMCID: PMC10509736     PMID: 37736343     Scopus ID: 85172768741    
Original Article
Mina Yousefnezhad, Soodabeh Davaran* ORCID, Mirzaagha Babazadeh, Abolfazl Akbarzadeh, Hamidreza Pazoki-Toroudi
Bioimpacts. 2023;13(3): 241-253. doi: 10.34172/bi.2023.24252
PMCID: PMC10329752     PMID: 37431480     Scopus ID: 85157052599    
Drug repurposing is an effective strategy for identifying and using approved drugs for new therapeutic purposes. We investigated co-delivery of the antitumor drugs, doxorubicin (DOX), and ezetimibe (EZ) as a cholesterol uptake-blocking drug with PCEC on prostate cancer cell line (PC3).
Original Article
Mitra Torabi ORCID, Ayuob Aghanejad*, Pouria Savadi ORCID, Abolfazl Barzegari, Yadollah Omidi ORCID, Jaleh Barar* ORCID
Bioimpacts. 2023;13(3): 255-267. doi: 10.34172/bi.2023.25298
PMCID: PMC10329750     PMID: 37431477     Scopus ID: 85158830047    
Owing to their unique advantages, mesoporous silica nanoparticles (MSNPs) have attracted much attention for drug delivery and targeting. In the current study, MSNPs were fabricated, PEGylated, loaded with sunitinib, and conjugated with mucin-16 aptamer to target CA125 on ovarian cancer cells.
Original Article
Nahid Moradi ORCID, Mina Soufi-Zomorrod* ORCID, Simzar Hosseinzadeh, Masoud Soleimani
Bioimpacts. 2024;14(3): 27510. doi: 10.34172/bi.2023.27510
PMCID: PMC11199929     PMID: 38938758     Scopus ID: 85194772548    
PDF
XML
Cited By:
Original Article
Azadeh Vaezi Moghaddam ORCID, Seyed Alireza Mortazavi* ORCID, Farzad Kobarfard, Reza Bafkary, Behzad Darbasizadeh
Bioimpacts. 2023;13(6): 456-466. doi: 10.34172/bi.2023.27548
PMCID: PMC10676526     PMID: 38022378     Scopus ID: 85172779411    
Original Article
Seyedeh-Sara Hashemi* ORCID, Mohsen Pirmoradi, Alireza Rafati, Mehdi Kian, Ali Akbar Mohammadi* ORCID, Mohamad Ali Hoghoughi*
Bioimpacts. 2024;14(5): 27748. doi: 10.34172/bi.2024.27748
PMCID: PMC11406428     PMID: 39296797     Scopus ID: 85209242629    
PDF
XML
Cited By:
Original Article
Samaneh Rashtbari ORCID, Zahra Hassanpour Aydinlou ORCID, Leila Sadeghi* ORCID
Bioimpacts. 2024;14(5): 29946. doi: 10.34172/bi.2024.29946
PMCID: PMC11406425     PMID: 39296801     Scopus ID: 85209094628    
PDF
XML
Cited By:
Review
Navid Mosallaei ORCID, Amirhossein Malaekeh-Nikouei ORCID, Setayesh Sarraf Shirazi, Javad Behmadi, Bizhan Malaekeh-Nikouei* ORCID
Bioimpacts. 2024;14(6): 30136. doi: 10.34172/bi.2024.30136
PMCID: PMC11530970     PMID: 39493899     Scopus ID: 85209575998    
PDF
XML
Cited By:
Original Article
Nahid Rezazadeh ORCID, Effat Alizadeh, Somaieh Soltani, Soodabeh Davaran* ORCID, Neda Esfandiari* ORCID
Bioimpacts. 2024;14(6): 30159. doi: 10.34172/bi.2024.30159
PMCID: PMC11530965     PMID: 39493895     Scopus ID: 85196320454    
PDF
XML
Cited By:
Original Article
Azin Shahmohammadi ORCID, Hadi Samadian, Saeed Heidari Keshel, Khodabakhsh Rashidi, Amir Kiani, Masoud Soleimani*, Farjam Goudarzi* ORCID
Bioimpacts. 2024;14(5): 30193. doi: 10.34172/bi.2024.30193
PMCID: PMC11406429     PMID: 39296800     Scopus ID: 85196029530    


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge